Clinical Presentations

In this week's Homerun Slides, testing albuminuria and potassium levels.

In this week's Homerun Slides, an explanation of some important diabetes trials such as EPPIC, SUN, BEACON, etc.

In this week's Homerun Slides, therapeutic approaches to chronic kidney disease beyond the renin–angiotensin system.

In this week's Homerun Slides, results of the HOPE trial and LIFE Study, and the main mediators that contribute to chronic kidney disease.

In this week's Homerun Slides, health conditions potentially indicated by albuminuria levels.

In this week's Homerun Slides, the significance of albuminuria.

In this week's Homerun Slides, the summary of the role of plasma protein (S1P) in glycocalyx protection.

In this week's Homerun Slides, schema of the action of the Glycocalyx.

Insulin sensitivity based upon the OGTT: The previous discussion suggests that “quick and dirty” indices from fasting values may not be accurate, and it is often true that laboratory procedures are impractical. Recently, it has been suggested that indices calculated from the OGTT may be useful for population studies. For decades the OGTT has been used as a screening test and a diagnostic tool for diabetes and IGT. It might be ideal if one could classify the state of carbohydrate tolerance and simultaneously measure insulin sensitivity and beta-cell function.

In this week's Homerun Slides, Dr. Claude Lardinois focuses on the importance of albuminuria as it relates to chronic kidney disease in people with type 2 diabetes.